A Chemoenzymatic Approach To Produce a Cyclic Analogue of the Analgesic Drug MVIIA (Ziconotide).


Journal

Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543

Informations de publication

Date de publication:
17 07 2023
Historique:
received: 23 02 2023
medline: 12 7 2023
pubmed: 6 5 2023
entrez: 6 5 2023
Statut: ppublish

Résumé

Ziconotide (ω-conotoxin MVIIA) is an approved analgesic for the treatment of chronic pain. However, the need for intrathecal administration and adverse effects have limited its widespread application. Backbone cyclization is one way to improve the pharmaceutical properties of conopeptides, but so far chemical synthesis alone has been unable to produce correctly folded and backbone cyclic analogues of MVIIA. In this study, an asparaginyl endopeptidase (AEP)-mediated cyclization was used to generate backbone cyclic analogues of MVIIA for the first time. Cyclization using six- to nine-residue linkers did not perturb the overall structure of MVIIA, and the cyclic analogues of MVIIA showed inhibition of voltage-gated calcium channels (Ca

Identifiants

pubmed: 37148162
doi: 10.1002/anie.202302812
doi:

Substances chimiques

ziconotide 7I64C51O16
omega-Conotoxins 0
Analgesics 0
Conotoxins 0
Calcium Channels 0
Calcium Channel Blockers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202302812

Informations de copyright

© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Références

Angew Chem Int Ed Engl. 2023 Jul 17;62(29):e202302812
pubmed: 37148162
Chem Rev. 2019 Sep 11;119(17):9836-9860
pubmed: 30990310
J Mol Recognit. 2000 Mar-Apr;13(2):55-70
pubmed: 10822250
J Med Chem. 2020 Oct 22;63(20):11615-11638
pubmed: 33026811
Biochemistry. 2000 Apr 11;39(14):3908-19
pubmed: 10747778
Angew Chem Int Ed Engl. 2019 Dec 19;58(52):19073-19080
pubmed: 31617285
Biochemistry. 1995 Aug 15;34(32):10256-65
pubmed: 7640281
J Biomol NMR. 1995 Jan;5(1):67-81
pubmed: 7881273
Chem Rev. 2019 Nov 13;119(21):11510-11549
pubmed: 31633928
Biopolymers. 2010;94(3):307-13
pubmed: 20013812
Antioxid Redox Signal. 2011 Jan 1;14(1):87-95
pubmed: 20486767
J Med Chem. 2020 Nov 12;63(21):12682-12692
pubmed: 33063995
Angew Chem Int Ed Engl. 2019 Oct 28;58(44):15904-15909
pubmed: 31398275
J Mol Biol. 2015 Jan 16;427(1):158-175
pubmed: 25088688
Mar Drugs. 2021 Feb 11;19(2):
pubmed: 33670311
Chem Rev. 2019 Sep 11;119(17):9971-10001
pubmed: 31318534
Curr Med Chem. 2004 Dec;11(23):3029-40
pubmed: 15578997
Biopolymers. 2013 Sep;100(5):492-501
pubmed: 23893856
J Mol Biol. 1999 Jun 25;289(5):1405-21
pubmed: 10373375
Chem Biol Drug Des. 2013 Jan;81(1):136-47
pubmed: 23253135
Angew Chem Int Ed Engl. 2010 Sep 3;49(37):6545-8
pubmed: 20533477
Curr Pharm Des. 2017;23(14):2131-2138
pubmed: 28245769
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13767-72
pubmed: 16162671
J Mol Biol. 1996 Oct 25;263(2):297-310
pubmed: 8913308
Nat Commun. 2021 Feb 8;12(1):870
pubmed: 33558523
Neuromodulation. 2014 Jul;17(5):472-82; discussion 482
pubmed: 24512055
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11241-6
pubmed: 26297249
J Biol Chem. 2017 Oct 13;292(41):17101-17112
pubmed: 28851841
Biochem Biophys Res Commun. 1995 Jan 17;206(2):449-54
pubmed: 7826361
Biochemistry. 1995 Jun 27;34(25):8076-81
pubmed: 7794920
Commun Chem. 2021 Mar 5;4(1):30
pubmed: 36697775
Neuropharmacology. 2016 Feb;101:137-45
pubmed: 26344359
Nature. 2021 Aug;596(7870):143-147
pubmed: 34234349
J Med Chem. 2011 Oct 13;54(19):6984-92
pubmed: 21888386
Chembiochem. 2021 Jun 15;22(12):2079-2086
pubmed: 33687132
Science. 1994 Nov 4;266(5186):776-9
pubmed: 7973629

Auteurs

Yan Zhou (Y)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Peta J Harvey (PJ)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Johannes Koehbach (J)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Lai Yue Chan (LY)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Alun Jones (A)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Åsa Andersson (Å)

Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Irina Vetter (I)

School of Pharmacy, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Thomas Durek (T)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

David J Craik (DJ)

ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, 4072, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH